Related Experiment Videos
Endothelin has potent inotropic effects in rat atria
J R Hu1, R Von Harsdorf, R E Lang
1German Institute for High Blood Pressure Research, University of Heidelberg, F.R.G.
European Journal of Pharmacology
|December 13, 1988
Summary
Endothelin, a potent vasoconstrictor, also significantly increases heart muscle contraction. This novel peptide acts directly on cardiac myocytes at nanomolar concentrations, revealing a dual role in cardiovascular function.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
- Molecular Biology
Background:
- Endothelin is a newly identified peptide derived from aortic endothelial cells.
- It is recognized as a highly potent vasoconstrictor.
- Its physiological roles beyond vasoconstriction are under investigation.
Purpose of the Study:
- To investigate the effects of endothelin on cardiac contractility.
- To determine if endothelin has direct actions on heart muscle cells.
Main Methods:
- Experiments were conducted using isolated rat heart atria.
- The inotropic effects of endothelin were measured at nanomolar concentrations.
Main Results:
- Endothelin demonstrated potent inotropic effects on isolated rat heart atria.
- These effects were observed at very low, nanomolar concentrations.
- Evidence suggests a direct action of endothelin on cardiac myocytes.
Conclusions:
- Endothelin possesses significant inotropic properties, in addition to its vasoconstrictor activity.
- The peptide directly influences cardiac myocyte contractility.
- Endothelin plays a dual role in cardiovascular regulation, affecting both blood vessels and the heart muscle.